Interestingly mutations in the AKT-pathway are not commonly found in MM [72], suggesting an alternative mechanism of AKT-pathway activation as a consequence of other deregulated pathways, such as the MAPK pathway, Il-6 signaling, or the NFκB network [73,74,75,76,77]. This evidence concerns the gene NFKB1 and Miyoshi myopathy.